I

iBio
D

IBIO

2.69500
USD
0.25
(10.00%)
Market Open
Volume
1,906
EPS
-8
Div Yield
-
P/E
-11
Market Cap
24,657,822
OverviewSignalsIdeasNews
Related Instruments
    A
    ABEO
    -0.09500
    (-1.60%)
    5.85500 USD
    A
    ABMD
    0
    (0%)
    0.000000 USD
    A
    ACER
    0
    (0%)
    0.000000 USD
    A
    ACRS
    -0.14500
    (-6.62%)
    2.04500 USD
    A
    ADAP
    -0.00320
    (-0.54%)
    0.58680 USD
    A
    ADC
    0.399
    (0.53%)
    75.979 USD
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    B
    BCLI
    0.06500
    (5.75%)
    1.19500 USD
    More
News

Title: iBio

Sector: Healthcare
Industry: Biotechnology
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.